PILOT TRIAL OF SAQUINAVIR AND NUCLEOSIDE ANALGOGUES PLUS INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE IN PATIENTS WITH HIV-ASSOCIATED NON-HODGKIN'S LYMPHOMA